CHEMO PROFIT MOTIVE

Is your Oncologist looking out for your needs or their own?

The American Society of Clinical Oncologists (ASCO) says, “Oncologists should make chemotherapy treatment recommendations on the basis of published reports of clinical trials and a patient’s health status and treatment preferences.” This was printed in Journal of Clinical Oncology, August 20, 2011 vol. 29, no. 24; 3328-3330. By: Burstein et al, American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays.
Documentation

How about those published reports of clinical trials?

More chemotherapy is given for breast cancer than for any other cancer and there have been more published reports clinical trials for breast cancer than for any other form of cancer. Yet with all this data, the NCI’s (National Cancer Institute) official cancer information website on state of the art chemotherapy for recurrent or metastatic breast cancer makes it clear that no clear consensus on treatment has been reached.
Documentation

What treatment protocol should be used?

“Whether single-agent chemotherapy or combination chemotherapy is preferable for first-line treatment is unclear. ” -NCI

What is the best drug or regimen for me?

“At this time, no data support the superiority of any particular regimen.”-NCI

British Medical Journal, 2003; 326
Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. By: Melander, Ahlqvist-Rastad, Meijer and Beermann.
“…for anyone who relies on published data alone to choose a specific drug, our results should be a cause for concern…any attempt to recommend a specific drug is likely to be based on biased evidence.”
Documentation

So, it would appear that published reports of clinical trials provide little in the way of guidance. In the absence of real guidance from published reports of clinical trials, what is the basis for chemotherapy treatment selection?

Profit? Let’s look at what the studies show.

1. The Journal of the National Cancer Institute (JNCI) commented that “private-practice oncologists typically derive two-thirds of their income from selling chemotherapy” (JNCI 2001;93:491).
Documentation

2. The Quality of Cancer Care: Models of Excellence
A proposal submitted to the National Cancer Policy board August 31, 1998
By: Dr. Thomas J. Smith, MD, FACP
Dr. Christopher E. Desch, M.D, FACP
Dr. Bruce E. Hillner, MD, FACP

From the Massey Cancer Center and the Department of Internal Medicine at Virginia Commonwealth University
“…oncology incomes are dependent on interventions*. “Chemotherapy is the only commodity sold in large quantities in doctor’s offices in the United States.” Many guidelines would restrict the use of chemotherapy and supportive care upon which current physician incomes are based. For example, in our current practice, billing for chemotherapy could mean the difference between an annual salary of $220,000 and $40,000.” * An act that alters the course of a disease, injury, or condition by initiating a treatment or performing a procedure.
Documentation

3. Health Affairs, Volume 25, no.2 (2006):pages 437-443
Does Reimbursement Influence Chemotherapy Treatment For Cancer Patients?
By: Mireille Jacobson, A. James O’Malley, Craig C. Earle, Juliana Pakes, Peter Gaccione and Joseph P. Newhouse. In a joint Michigan/ Harvard study of 9,357 patients, the authors documented a clear association between reimbursement to the oncologists for the chemotherapy of breast, lung, and colorectal cancer and the regimens which the oncologists selected for the patients. In other words, this study confirms that oncologists tended to choose cancer chemotherapy regimens based on how much money the chemotherapy earns the oncologists.
Documentation

4. The Online Journal of Health Ethics, Volume 3, Issue 1, Article 1. Reimbursements sway Oncologists’ Drug Choices ‘Letter to Editor’, By: Gregory D. Pawelski.
Regarding the Michigan/ Harvard study entitled ‘Does reimbursement influence chemotherapy treatment for cancer patients.’ “It confirmed that medical oncologists chose cancer therapy based on how much money the chemotherapy earns the medical oncologist.”
Documentation

Below is the March 8, 2006 New York Times article describing the study:
Documentation

One of the more interesting aspects of this story is the following:
[Quoted from the above New York Times article]:
“An executive with the American Society of Clinical Oncology, Dr. Joseph S. Bailes, disputed the study’s findings, saying that cancer doctors select treatments only on the basis of clinical evidence. ‘All of us are looking at clinical trials,’ he said.”

So, ASCO’s Dr. Bailes maintains that drugs are chosen only on the basis of “clinical evidence.” Well, here’s what’s odd about that statement:

5. In Patterns of Care in Medical Oncology, volume 2, issue 1, 2005, Dr. Neil Love, M.D., wrote “Management of Breast Cancer in the adjuvant and Metastatic Settings.” Dr. Love reported a survey of (1) breast cancer oncologists based in academic medical centers who do not derive personal profit from the administration of infusion (i.v.) chemotherapy and (2) community based, private practice medical oncologists who do derive personal profit from infusion (i.v.) chemotherapy, while deriving no profit from prescribing oral-dosed chemotherapy. The results of the survey could not have been more clear-cut. For first line chemotherapy of metastatic breast cancer, 84-88% of the academic center-based oncologists prescribed an oral dose drug (capecitabine), while only 13% perscribed infusion (i.v.) drugs, and none of them prescribed the expensive, highly remunerative drug docetaxel. In contrast, among the community-based oncologists, only 18% prescribed the oral dose drug (capecitabine), while 75% prescribed infusion (i.v.) drugs, and 29% prescribed the expensive, highly remunerative drug docetaxel. The existence of this profit motive in drug selections is clearly not based on the interests of the patient, but on the income of the oncologist.
Documentation

6. New York Times– 2007, Cancer Drug Representatives Spelled Out the Way to Profit
Dr. Robert Geller, an oncologist who worked in private practice from 1996 to 2005 before leaving to join a biotechnology company, said that cancer doctors knew the profits they could make and in some cases would change treatment regimens or offer unnecessary care to make extra money.
“It’s clear that physicians stopped making decisions based on what made scientific or clinical sense in lieu of what made better business sense,” Dr. Geller said.
Documentation

7. Journal of Oncology Practice, 2011 Mar; 7(2 Suppl): 2s–15s.
National Oncology Practice Benchmark: An Annual Assessment of Financial and Operational Parameters—2010 Report on 2009 Data By: Thomas R. Barr, MBA and Elaine L. Towle, CMPE, “On average, 65% of oncology revenue comes from the administering of drugs.”
Documentation

8. Journal of Clinical Oncology, Vol 31, No 5 (February 10), 2013: pp 530-535
Medical oncologists’ perceptions of financial incentives in cancer care. By: Malin et al.
“A substantial proportion of oncologists who are not paid a fixed salary report that their incomes increase when they administer chemotherapy and growth factors…The chemotherapy concession is the source of approximately 65% of the revenue in a typical oncology practice dwarfing the income from evaluation and management.”
Documentation

9. Journal of Clinical Oncology, Vol 31, No 5 (February 10), 2013: pp 517-519
Are Oncologists’ Financial Incentives Aligned With Quality Care? By: Yu-Ning Wong
“The work by Malin et al complements other empirical data that suggest that oncologists respond to financial incentives…an oncologist is much more generously reimbursed for administering an expensive intravenous drug than having a complicated end-of-life conversation with a patient and family.”
Documentation

10. Journal of Clinical Oncology, Vol 31, No 23 (August 10), 2013: pp 2973-2974
Financial Incentives in Cancer Care and Impact on Prescribing Practice
Hui-li Wong, Kathryn M. Field, Jeremy D. Shapiro, Joseph J. McKendrick, and Peter Gibbs
“It would be naive to think that medical oncologists are immune to the attraction of financial incentives that affect their practice.”
Documentation

11. Journal of Clinical Oncology, 2014, Vol 32, No 36 (December 20), pp 4027-4028
Payment for Cancer Care: Time for a New Prescription
By: Lowell E. Schnipper, Harvard Medical School, Boston, MA, &
Neal J. Meropol, Case Western Reserve University, Cleveland, OH.
“The hypothesis that physician behavior is impacted by reimbursement in an FFS (fee-for-service) environment is supported by many studies. For example, Hadley et al1 found that use of breast-conserving surgery rather than mastectomy was more frequent in geographic regions in which reimbursement was higher. Others have found that following the MMA (Medicare Prescription Drug, Improvement, and Modernization Act), chemotherapy use was increased for drugs that maintained more generous reimbursement.”2,3
Documentation

1. Hadley J, Mitchell JM, Mandelblatt J: Medicare fees and small area variations in breast-conserving surgery among elderly women. Med Care Res Rev 58:334-360, 2001 LINK
2. Jacobson M, Earle CC, Price M, et al: How Medicare’s payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) 29:1391-1399, 2010 LINK
3. Jacobson M, O’Malley AJ, Earle CC, et al: Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) 25:437-443, 2006 LINK

12. Dr. Ezekiel J. Emanuel, Ph.D., chairman of the department of clinical bioethics at the National Institutes of Health, ruffled more than a few feathers at the annual meeting of the American Society of Clinical Oncology in May of 2001. His presentation was later published in the Annals of Internal Medicine, 2003 Apr 15;138(8):639-43. The title is Chemotherapy use among Medicare beneficiaries at the end of life.
Dr. Emanuels’s presentation was a news sensation since it pointed directly to greed as a motivating factor in elderly patient care. His study clearly demonstrated that many cancer patients receive chemotherapy at the end of life, even if their kind of cancer is known to be unresponsive to the drugs. His findings ”strongly suggests overuse of chemotherapy at the end of life.”

CONCLUSION:
“Among patients who died of cancer, chemotherapy was used frequently in the last 3 months of life. The cancer’s responsiveness to chemotherapy does not seem to influence whether dying patients receive chemotherapy at the end of life.”
Documentation

The Philippine Daily Inquirer Reported the story, “Chemotherapy unjustified at times, says study.”
Documentation

The British Medical Journal reported, “Chemotherapy may be overused at the end of life.”
Documentation

The New York Times reported, “Study suggests overuse of chemotherapy near life’s end.”
Documentation

The New York Post printed, “STUDY: CHEMO WASTED ON TERMINAL PATIENTS.”
Documentation

13. The Journal of the National Cancer Institute, 1992, 84 (10): 810.
An Ethical Approach to Chemotherapy in Private Practice, by Dr. David Young, M.D.
Regarding patient treatment ethics,“there are physicians who disregard these principles in order to maintain a very lucrative chemotherapy practice. Patients are routinely continued on ineffective chemotherapy despite obvious progression of disease. Others are given adjuvant chemotherapy for long periods, even extending to 5 years for high-risk resected tumors, despite a lack of supportive studies…Physicians who knowingly prescribe ineffective chemotherapy to patients with refractory cancers are unlikely to be challenged, given that community non-oncologists and insurance representatives have no mechanism to identify ineffective treatment.”
Documentation

14. The New England Journal of Medicine, 2011; 364:2060-2065
Bending the Cost Curve in Cancer Care. By: Dr. Thomas J. Smith, M.D., and Dr. Bruce E. Hillner, M.D. “Medicare data have clearly shown that some oncologists choose chemotherapy in order to maximize income for their practice. A system in which over half the profits in oncology are from drug sales is unsustainable.”
Documentation

15. New York Times– 2007, Incentives Limit Any Savings in Treating Cancer
“There’s pretty good evidence at this point,” said Dr. Richard Deyo, M.D., professor of medicine at the University of Washington, “that there are plenty of patients for whom there’s little hope, who are terminally ill, whom chemotherapy is not going to help, who get chemotherapy.” Dr. Robert Geller, M.D., says, “When you start thinking of oncology as a business, then all these decisions make sense.”
Documentation

16. BMC Health Services Research, 2012, 12:481
Unsupported off-label chemotherapy in metastatic colon cancer, by; de Souza et al.
“We found considerable utilization of expensive anticancer regimens in metastatic colon cancer without supporting evidence… more than one in eight patients received at least one regimen that is not considered standard of care.”
Documentation

Health- “Chemo for Late-Stage Cancer Patients May Be Unjustified”
University of Chicago- ”Many patients with advanced cancers get treatments that won’t help“

17. PLoS Medicine, 2011, 8(4): e1000431.
Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
By: Kesselheim et al.
This study stated that Pharmaceutical manufacturers encouraged: off-label use through direct financial incentives to physicians… Lavish gifts or honoraria were mentioned in most complaints (35/41, 85%), with many whistleblowers reporting strategies to target these gifts to physicians who were high off-label prescribers (18/41, 44%). In some cases, physicians might be invited to serve in focus groups or as consultants to the manufacturer…not to obtain expert advice, but to provide money to prescribers to positively reinforce off-label use.”
Documentation

18. The New York Times Dr. Drug Rep, November 25, 2007, By. Dr. Daniel Carlat, M.D.
“…one recent study indicates that at least 25 percent of all doctors in the United States receive drug money for lecturing to physicians or for helping to market drugs in other ways.”
Documentation

19. Journal of Oncology Practice, November 2011, vol. 7 no. 6S, pages 67s-82s.
National Oncology Practice Benchmark, 2011 Report on 2010 Data, By: Thomas R. Barr, MBA and Elaine L. Towle, CMPE. Drugs and infusion revenue accounted for 73% of total revenue in 37 oncology practices, while evaluation and management activities were responsible for only 8% of this revenue.
Documentation

“My doctor gave me six months to live, but when I couldn’t pay the bill he gave me six months more.” -Walter Matthau

According to Medscape, Oncologists were the 10th highest ranked specialty, with an average income of $278,000. About 10% of oncologists earn $500,000 or more; about 14% earn $100,000 or less. The commission profit from chemotherapy drugs administered in their offices is very lucrative and unique to Oncologists.

You can’t really think the “profit motive” is anything new in medicine, can you?

Here are two significant examples of excess profiteering in medicine from a U.S. Congressional Report.

United States Congress, Health care reform : hearings before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Third Congress, first session November 10, 1993.

Pages 381-382
“A 1991 study by the state of Florida found that physicians in that state own the vast majority of certain health care facilities, and that these ownership arrangements have led doctors to order unnecessary tests and questionable treatments in order to increase their profits.The report, commissioned by the Florida Health Care Cost Containment Board, found that at least 40 percent of the practicing doctors in the state have invested in facilities to which they can refer patients. In the case of diagnostic-imaging centers, the study found that doctors own 93 percent of such facilities. In addition, the study reported that the number of tests per patient is almost twice as great in doctor-owned labs than in those not owned by doctors. Likewise, the average per patient charge in a joint venture facility was more than twice the charge in a non-joint venture lab.”
Suplee, Curt, “Florida Reviews Ownership of Clinics,” The Washington Post . August 9, 1991.
Documentation

Page 382
“The Consumer Federation of America reported similar findings in their study of doctor ownership of diagnostic testing facilities. The report concluded, “The rapid spread of physician ownership of diagnostic testing facilities is a much more likely cause of rising diagnostic costs than defensive medicine.”” The report found that physicians own or have compensation arrangements with one-third to one-half of all clinical laboratories. In the field of Magnetic Imaging Centers, physician ownership was found to exceed 50 percent The study also reported:
* Compared to tests ordered at independent labs, self-dealing physicians ordered 34 to 96\percent more tests;
* Prices are 2 to 38 percent higher at physician-owned labs than at independent labs;
* The total bill was 25 to 125 percent higher for physician-owned labs.”
Cooper, Mark N., “Physician Self-Dealing for Diagnostic Tests in the 1980s: Defensive Medicine vs. Offensive Profits,” Consumer Federation of America, October, 1991.
Documentation

Congressional Budget Office: Increasing the value of federal spending on health care.
Testimony before the Committee on the Budget, U.S. House of Representatives July 16, 2008
The Congressional Budget Office estimates that up to 30% of care delivered in the United
States goes toward unnecessary tests, procedures, physician visits, hospital stays, and other services, which include ineffective cancer treatments.
Documentation

Drug companies pay oncologists to promote (expensive) ineffective and toxic cancer drugs

2012- Global health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of certain drugs.

As part of the criminal agreement with the U.S. Department of Justice, GSK agreed to resolve its civil liability for the promotion of drugs for off-label, noncovered uses, paying kickbacks to physicians to prescribe those drugs, making false and misleading statements concerning drug safety, and reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program.

“Patients rely on their physicians to prescribe the drugs they need. The pharmaceutical industries’ drive for profits can distort the information provided to physicians concerning drugs. This case will help to ensure that your physician will make prescribing decisions based on good science and not on misinformation, money or favors provided by the pharmaceutical industry.” -John Walsh, U.S. Attorney for Colorado.
Documentation

Department of Justice case link

This isn’t the first time a big Pharma company has been “pinched” for illegal activities.

In 2007, Merck agreed to pay nearly $5 billion to settle lawsuits from consumers contending the painkiller Vioxx caused heart attacks and strokes. On NPR we got a very insightful quote from Dr. Catherine DeAngelis, M.D. editor of the Journal of the American Medical Association (JAMA). “What people should learn from this is you don’t believe anything, not one thing, put out by a pharmaceutical company. Just don’t believe it. You start from there. When you want to make money by selling products to people who don’t need it rather than putting your money into developing new drugs, then you’re going to get into this kind of trouble.” LISTEN HERE DeAngelis.mp3 “DeAngelis says she used to be skeptical of drug companies; now she’s cynical.”
Department of Justice case link   NPR link

vioxx-and-merck

“If all pharmaceutical manufacturers complied with the law, there would be no need for law enforcement actions,” says Susan Waddell, Special Agent in Charge for the Office of Inspector General of the U.S. Department of Health and Human Services“But until they stop abusing the health care system and putting profits ahead of patient safety, OIG will continue to vigorously pursue corporations that flout the law.”

how-much-money-is-in-oncology-gonzalesHow much money is in oncology Gonzales

oncologist-bonus-structureOncologist Bonus structure

how-much-does-chemotherapy-costHow much does chemotherapy cost

pharmaceutical-sales-rep-tacticsPharmaceutical Sales Rep Tactics

all-chemotherapy-agents-are-carcinogenicsAll chemotherapy agents are carcinogenics

audio-after-3-rounds-of-chemo-failure-a-4th-round-is-just-stupidAfter 3 rounds of chemo failure a 4th round is just stupid

big-pharma-big-money_documentary-on-the-money-and-corruption-of-big-pharmaceutical-companiesBig Pharma Big Money Documentary on the Money and Corruption of Big Pharmaceutical Companies

cancer-drugs-are-very-expensiveCancer drugs are very expensive

cbs-news-optimism-about-chemoCBS news optimism about chemo

chemo-journeyChemo Journey

chemo-scientific-american-john-cairnsChemo Scientific American John Cairns

chemotherapy-can-boost-cancer-growth-foxChemotherapy can boost cancer growth Fox

chemotherapy-chemist-secretsChemotherapy Chemist Secrets

chemotherapy-is-a-waste-of-moneyChemotherapy is a Waste of Money

chemotherapy-is-not-effective-for-90-percent-of-cancersChemotherapy is Not Effective for 90 Percent of Cancers

chemotherapy-really-is-poisonChemotherapy really is poison

chemo-will-only-to-cure-2-percent-this-yearChemo will only to cure 2 percent this year

audio-cancer-docs-talk-about-ineffective-chemoAudio Cancer docs talk about ineffective chemo

chemo-drugs-threats-to-health-care-workersChemo Drugs Threats to Health Care Workers

chris-wark-chemotherapy-causes-more-cancerChris Wark Chemotherapy Causes More Cancer

dr-jimenez-chemo-3-percentDr Jimenez chemo 3 percent

dr-gonzalez-explains-why-chemo-is-so-ineffectiveDr Gonzalez Explains why chemo is so ineffective

does-it-make-sense-to-use-carcinogens-to-treat-cancerDoes it make sense to use carcinogens to treat cancer

does-chemo-cause-cancer-gonzalesDoes chemo cause cancer Gonzales

chris-wark-medicine-is-not-science-basedChris Wark Medicine is NOT Science Based

chemo-is-carcinogenicChemo is carcinogenic

chemo-radiation-and-surgery-are-largely-ineffectiveChemo Radiation and Surgery are largely ineffective

abc-news-the-prevalence-of-hospital-errorsABC news the prevalence of hospital errors

dr-lodi-conventional-medicine-doesnt-workDr Lodi Conventional medicine doesnt work

am-i-doing-what-is-best-for-the-patientAm I doing what is best for the patient

blind-obedience-can-kill-you-question-your-doctorBlind obedience can kill you question your doctor

chemo-surgery-and-radiation-are-not-very-effectiveChemo surgery and radiation are not very effective

medicines-should-be-the-last-resort-not-the-firstMedicines should- be the last resort not the first

pharmaceutical-companies-influence-education-with-gifts-and-fundingPharmaceutical companies influence education with gifts and funding

prescriptions-are-not-the-answerPrescriptions are not the answer

chemotherapy-boosting-cancer-growthChemotherapy Boosting Cancer Growth

fake-cancer-drugs-originate-in-chinaFake cancer drugs originate in China

inside-the-deadly-pakistan-counterfeit-drug-tradeInside the deadly Pakistan counterfeit drug trade

abc-news-counterfeit-cancer-drugsABC news Counterfeit Cancer Drugs

even-us-doctors-buy-unapproved-and-fake-cancer-drugsEven US doctors buy unapproved and fake cancer drugs

fake-drugs-confiscated-by-nbi-and-fdaFake drugs confiscated by NBI and FDA

fda-approval-is-often-based-on-conflicts-of-interestFDA approval is often based on conflicts of interest

60-minutes-the-fight-against-counterfeit-drugs60 Minutes the fight against counterfeit drugs

be-confident-on-your-chosen-treatmentBe confident on your chosen treatment

Facebook
Google+
Twitter
YouTube
Instagram
 

To access the drfarrahcancercenter.com site, you must agree to the following;

Terms of Use

OVERVIEW

Please read these Terms of Use carefully before accessing or using our website. By accessing or using any part of the site, you agree to be bound by these Terms of Use. If you do not agree to all the terms and conditions of this agreement, then you may not access the website or use any services.

This website is operated by private parties in the Republic of Panama. Throughout the site, the terms “we”, “us” and “our” refer to drfarrahcancercenter.com, which offers this website, including all information, tools and services available from this site to you, the user, conditioned upon your acceptance of all terms, conditions, policies and notices stated here.

You understand and agree that you are accessing a website registered, owned, and hosted in the Republic of Panama. Therefore, all issues of a legal nature fall under the jurisdiction of the Republic of Panama legal system.

You understand and agree that as an authorized user you may only access information to which you have the legal authority to view and use. drfarrahcancercenter.com will monitor and record activity on this system to protect the system and its information and may use that monitoring information for official administrative or legal purposes. You understand and agree that you are not permitted to record, screenshot, or disseminate any information contained on the drfarrahcancercenter.com website to any party for any purpose whatsoever, and as such, you agree not to engage in such banned activities.

You understand and agree that unauthorized use of the system such as gaining unauthorized access to data, changing data, causing harm to the system or its data, or misuse of components is prohibited and may result in criminal, civil, or administrative penalties.

You also understand that drfarrahcancercenter.com can suspend or stop your use of this system if drfarrahcancercenter.com suspects any unauthorized use of the system attributable to you has occurred.

Your access to and use of the drfarrahcancercenter.com site is conditioned on your acceptance of and compliance with these Terms. These terms apply to all visitors, users and others who access or use the drfarrahcancercenter.com site. By accessing or using the drfarrahcancercenter.com site, you agree to be bound by these Terms. If you disagree with any part of the following Terms of Use, then you may not access the drfarrahcancercenter.com site.

By visiting our site and/ or purchasing anything from us, you engage in our “Service” and agree to be bound by the following terms and conditions (“Terms of Use”, “Terms”), including those additional terms and conditions and policies referenced herein and/or available by hyperlink. These Terms of Use apply to all users of the site, including without limitation users who are browsers, vendors, customers, merchants, and/ or contributors of content.

Any new features or tools which are added to the current website shall also be subject to the Terms of Use. You can review the most current version of the Terms of Use at any time on this page. We reserve the right to update, change or replace any part of these Terms of Use by posting updates and/or changes to our website. It is your responsibility to check this page periodically for changes. Your continued use of or access to the website following the posting of any changes constitutes acceptance of those changes.

 

SECTION 1 – ONLINE WEBSITE TERMS

By agreeing to these Terms of Use, you represent that you are at least the age of majority in your state, province, country or city of residence, or that you are the age of majority in your state, province, country or city of residence and you have given us your consent to allow any of your minor dependents to use this site.

You may not use any of our website for any illegal or unauthorized purpose nor may you, in the use of the Service, violate any laws in your jurisdiction (including but not limited to copyright laws).

You must not transmit any worms or viruses or any code of a destructive nature.

A breach or violation of any of the Terms will result in an immediate termination of your Services.

 

SECTION 2 – GENERAL CONDITIONS

We reserve the right to refuse service to anyone for any reason at any time.

You agree not to reproduce, duplicate, copy, sell, resell or exploit any portion of the Service, use of the Service, or access to the Service or any contact on the website through which the service is provided, without express written permission by us.

The headings used in this agreement are included for convenience only and will not limit or otherwise affect these Terms.

You understand and agree that this website is for information purposes only, and that by providing the information contained herein, we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. You understand and agree that before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

You understand and agree that the information on the site is presented for the sole purpose of disseminating health information for general educational purposes only. You understand and agree that if you think you may have a medical emergency, you should call your doctor or 911. You understand and agree that the information on this site is not intended or implied to be medical advice, and you understand and agree that the information does not constitute the provision or practice of medical, nursing, or professional health care advice or services. You understand and agree that you will not use the information on this site as a substitute for professional medical advice, diagnosis, or treatment. You understand and agree that you should always seek the advice of your physician or other qualified health care provider prior to starting any treatment or with any questions you may have regarding a medical condition.

You understand and agree that nothing contained on this site is intended to be or will be used by you for medical diagnosis or treatment. You understand and agree that you should never disregard professional medical advice or delay in seeking treatment based on the information contained on this site. You understand and agree that the service and any content or information contained on the site is provided on an ‘as is’ basis. You understand and agree that while efforts have been made to assure the accuracy of the information on this site, there is no guarantee that such information is accurate or up-to-date. You understand and agree that, except for information, products, or services clearly identified as being supplied by the site, the site does not operate, control, or endorse any information, products, or services on the internet, in any way.

In addition, access to this site constitutes acceptance and understanding of the following,

By accessing this system, you hereby acknowledge, consent, and agree to all listed provisions and consent to monitoring.

You understand and agree that any copyright laws pertaining to the ownership and reproduction of all data fall exclusively under Panamanian legal jurisdiction for drfarrahcancercenter.com

If you are a copyright holder, or a director, officer, owner, employee, agent, supplier, licensor, contributor, service provider, website hosting company, trade partner, heir or assign of a copyright holder and feel that you or anyone you are engaged in any form of relationship whatsoever may have rights to data as part of this site or related sites, your agreement with the terms of use constitutes the following agreement, which is mandatory in order to access the data contained on this site.

I do hereby declare, understand, agree and warrant that I am a copyright owner, or an authorized representative of a copyright owner of film, print, slide, movie, video, artwork, digital image, negatives or any other material in any format whatsoever (hereafter referred to as “COPYRIGHTED DATA”) which I believe to be, known to be, or suspect to be contained on the drfarrahcancercenter.com website.

I hereby freely grant a non-exclusive license to drfarrahcancercenter.com and its agents to reproduce these COPYRIGHT DATA in perpetuity, and I represent and warrant that I have the legal right and authority to grant such a license. I may at my discretion ask to be credited for my contribution or the contributor I represent to the drfarrahcancercenter.com site as a contributor whether this occurred with or without my knowledge, but even if I or the contributor I represent remains uncredited, this agreement shall survive since participation in the free flowing of information for the public at large is a paramount responsibility we all should share. Therefore, in the best interest of free-flowing information for the public at large, I am freely undertaking this agreement, and clearly warrant that I have the authority to do so. I agree to indemnify and hold harmless drfarrahcancercenter.com and any of its directors, officers, owners, employees, agents, suppliers, licensors, contributors, service providers, website hosting companies, trade partners, heirs and assigns from any and all liability, damages, and expenses (including reasonable actual attorney’s fees) that may incur as a result of use and publication of said material, including any claims brought by any person claiming an interest in the COPYRIGHTED DATA or their subject matter. I agree and warrant that anyone containing any format of data from drfarrahcancercenter.com contained in any medium outside of the drfarrahcancercenter.com website itself, is bound by this agreement, since acceptance of this agreement is the only way to legally access such data. In addition, I understand and agree that accessing or storing any format of data contained in any medium outside of the drfarrahcancercenter.com website where it is hosted, constitutes a violation of the copyright laws of Panama against the offending party. I understand and agree that if I copy, contain, possess, or transmit any such data from the drfarrahcancercenter.com site in any format outside of the website itself, that my possession of such materials is a violation of Panamanian laws, and I agree to destroy such data forthwith.

 

SECTION 3 – ACCURACY, COMPLETENESS AND TIMELINESS OF INFORMATION

We are not responsible if information made available on this site is not accurate, complete or current. The material on this site is provided for general information only and should not be relied upon or used as the sole basis for making decisions without consulting primary, more accurate, more complete or more timely sources of information. Any reliance on the material on this site is at your own risk.

This site may contain certain historical information. Historical information, necessarily, is not current and is provided for your reference only. We reserve the right to modify the contents of this site at any time, but we have no obligation to update any information on our site. You agree that it is your responsibility to monitor changes to our site.

 

SECTION 4 – MODIFICATIONS TO THE SERVICE

We reserve the right at any time to modify or discontinue the Service (or any part or content thereof) without notice at any time.

We shall not be liable to you or to any third-party for any modification, change, suspension or discontinuance of the Service.

 

SECTION 5 – OPTIONAL TOOLS

Any use by you of optional tools offered through the site is entirely at your own risk and discretion and you should ensure that you are familiar with and approve of the terms on which tools are provided by the relevant third-party provider(s).

We may also, in the future, offer new services and/or features through the website (including, the release of new tools and resources). Such new features and/or services shall also be subject to these Terms of Use.

 

SECTION 6 – THIRD-PARTY LINKS

Certain content, products and services available via our Service may include materials from third-parties.

Third-party links on this site may direct you to third-party websites that are not affiliated with us. We are not responsible for examining or evaluating the content or accuracy and we do not warrant and will not have any liability or responsibility for any third-party materials or websites, or for any other materials, products, or services of third-parties.

We are not liable for any harm or damages related to the purchase or use of goods, services, resources, content, or any other transactions made in connection with any third-party websites. Please review carefully the third-party’s policies and practices and make sure you understand them before you engage in any transaction. Complaints, claims, concerns, or questions regarding third-party products should be directed to the third-party.

 

SECTION 7 – USER COMMENTS, FEEDBACK AND OTHER SUBMISSIONS

If, at our request, you send certain specific submissions (for example contest entries) or without a request from us you send creative ideas, suggestions, proposals, plans, or other materials, whether online, by email, by postal mail, or otherwise (collectively, ‘comments’), you agree that we may, at any time, without restriction, edit, copy, publish, distribute, translate and otherwise use in any medium any comments that you forward to us. We are and shall be under no obligation (1) to maintain any comments in confidence; (2) to pay compensation for any comments; or (3) to respond to any comments.

We may, but have no obligation to, monitor, edit or remove content that we determine in our sole discretion are unlawful, offensive, threatening, libelous, defamatory, pornographic, obscene or otherwise objectionable or violates any party’s intellectual property or these Terms of Use.

You agree that your comments will not violate any right of any third-party, including copyright, trademark, privacy, personality or other personal or proprietary right. You further agree that your comments will not contain libelous or otherwise unlawful, abusive or obscene material, or contain any computer virus or other malware that could in any way affect the operation of the Service or any related website. You may not use a false e-mail address, pretend to be someone other than yourself, or otherwise mislead us or third-parties as to the origin of any comments. You are solely responsible for any comments you make and their accuracy. We take no responsibility and assume no liability for any comments posted by you or any third-party.

 

SECTION 8 – ERRORS, INACCURACIES AND OMISSIONS

Occasionally there may be information on our site or in the Service that contains typographical errors, inaccuracies or omissions that may relate to product descriptions, pricing, promotions, offers, product shipping charges, transit times and availability. We reserve the right to correct any errors, inaccuracies or omissions, and to change or update information or cancel orders if any information in the Service or on any related website is inaccurate at any time without prior notice (including after you have submitted your order).

We undertake no obligation to update, amend or clarify information in the Service or on any related website, including without limitation, pricing information, except as required by law. No specified update or refresh date applied in the Service or on any related website, should be taken to indicate that all information in the Service or on any related website has been modified or updated.

 

SECTION 9 – PROHIBITED USES

In addition to other prohibitions as set forth in the Terms of Use, you are prohibited from using the site or its content: (a) for any unlawful purpose; (b) to solicit others to perform or participate in any unlawful acts; (c) to violate any international, federal, provincial or state regulations, rules, laws, or local ordinances; (d) to infringe upon or violate our intellectual property rights or the intellectual property rights of others; (e) to harass, abuse, insult, harm, defame, slander, disparage, intimidate, or discriminate based on gender, sexual orientation, religion, ethnicity, race, age, national origin, or disability; (f) to submit false or misleading information; (g) to upload or transmit viruses or any other type of malicious code that will or may be used in any way that will affect the functionality or operation of the Service or of any related website, other websites, or the Internet; (h) to collect or track the personal information of others; (i) to spam, phish, pharm, pretext, spider, crawl, or scrape; (j) for any obscene or immoral purpose; or (k) to interfere with or circumvent the security features of the Service or any related website, other websites, or the Internet. We reserve the right to terminate your use of the Service or any related website for violating any of the prohibited uses.

 

SECTION 10 – DISCLAIMER OF WARRANTIES; LIMITATION OF LIABILITY

We do not guarantee, represent or warrant that your use of our service will be uninterrupted, timely, secure or error-free.

We do not warrant that the results that may be obtained from the use of the service will be accurate or reliable.

You agree that from time to time we may remove the service for indefinite periods of time or cancel the service at any time, without notice to you.

You expressly agree that your use of, or inability to use, the service is at your sole risk. The service and all products and services delivered to you through the service are (except as expressly stated by us) provided ‘as is’ and ‘as available’ for your use, without any representation, warranties or conditions of any kind, either express or implied, including all implied warranties or conditions of merchantability, merchantable quality, fitness for a particular purpose, durability, title, and non-infringement.

In no case shall anyone affiliated with drfarrahcancercenter.com including our directors, officers, employees, affiliates, agents, contractors, interns, suppliers, service providers or licensors be liable for any injury, loss, claim, or any direct, indirect, incidental, punitive, special, or consequential damages of any kind, including, without limitation lost profits, lost revenue, lost savings, loss of data, replacement costs, or any similar damages, whether based in contract, tort (including negligence), strict liability or otherwise, arising from your use of any of the service or any products procured using the service, or for any other claim related in any way to your use of the service or any product, including, but not limited to, any errors or omissions in any content, or any loss or damage of any kind incurred as a result of the use of the service or any content (or product) posted, transmitted, or otherwise made available via the service, even if advised of their possibility. Because some states or jurisdictions do not allow the exclusion or the limitation of liability for consequential or incidental damages, in such states or jurisdictions, our liability shall be limited to the maximum extent permitted by law.

You understand and agree that no singular individual, group of individuals or entity in any form whatsoever is responsible or liable in any manner for any content generated on, for, or as a result of the existence of this site, since this is a community generated site. You understand and agree that as this is a community generated site, and as a result of this, there is no good way to control what users and contributors post on or through the sites and drfarrahcancercenter.com cannot be responsible for any offensive, inappropriate, obscene, unlawful, infringing or otherwise objectionable or even illegal user generated content you may encounter on the sites or, in connection with your use of the sites.

You understand and agree with the following statement made on behalf of drfarrahcancercenter.com, “We, on behalf of our directors, officers, employees, agents, suppliers, licensors, contributors and service providers, exclude and disclaim liability for any losses and expenses of whatever nature and howsoever arising including, without limitation, any direct, indirect, general, special, punitive, incidental or consequential damages; loss of use: loss of data; loss caused by a virus: loss of income or profit: loss of or damage to property: loss of life: claims of third parties: or other losses of any kind or character, or the inability to use, the site or the content even if we have been advised of the possibility of such damages or losses, arising out of or in connection with the use of this site or any web site with which it is linked.”

 

SECTION 11 – INDEMNIFICATION

You agree to indemnify, defend and hold harmless drfarrahcancercenter.com and our parent, subsidiaries, affiliates, partners, officers, directors, agents, contractors, licensors, service providers, subcontractors, suppliers, interns and employees, harmless from any claim or demand, including reasonable attorneys’ fees, made by any third-party due to or arising out of your breach of these Terms of Use or the documents they incorporate by reference, or your violation of any law or the rights of a third-party.

 

SECTION 12 – SEVERABILITY

In the event that any provision of these Terms of Use is determined to be unlawful, void or unenforceable, such provision shall nonetheless be enforceable to the fullest extent permitted by applicable law, and the unenforceable portion shall be deemed to be severed from these Terms of Use, such determination shall not affect the validity and enforceability of any other remaining provisions.

 

SECTION 13 – TERMINATION

The obligations and liabilities of the parties incurred prior to the termination date shall survive the termination of this agreement for all purposes.

These Terms of Use are effective unless and until terminated by us. You may terminate use of the drfarrahcancercenter.com site, but this Terms of Use shall survive in perpetuity.

If in our sole judgment you fail, or we suspect that you have failed, to comply with any term or provision of these Terms of Use, we also may terminate this agreement at any time without notice and you will remain liable for all amounts due up to and including the date of termination; and/or accordingly may deny you access to our Services (or any part thereof).

 

SECTION 14 – INDEMNIFICATION

The information supplied through this website, or by any representative or agent of Dr. Farrah, whether by telephone, in person verbal, email, letter, image, text, facsimile or any other conceivable form of communication, is for informational purposes only and does not constitute medical, legal or other professional advice. Health-related information provided through this website is not a substitute for medical advice and should not be used to diagnose or treat health problems or to prescribe any medical devices or other remedies. The receipt of any questions or feedback that you submit in any form to any Dr. Farrah medium does not create a professional relationship and does not create any privacy interests.
You agree to indemnify, defend and hold harmless drfarrahcancercenter.com and our parent, subsidiaries, affiliates, partners, officers, directors, agents, contractors, licensors, service providers, subcontractors, suppliers, interns and employees, harmless from any claim or demand, including reasonable attorneys’ fees, made by any third-party due to or arising out of your breach of these Terms of Service or the documents they incorporate by reference, or your violation of any law or the rights of a third-party.

 

SECTION 15 – GOVERNING LAW

These Terms of Use and any separate agreements whereby we provide you Services shall be governed by and construed in accordance with the laws of the Republic of Panama.

 

SECTION 16 – CHANGES TO TERMS OF USE

You can review the most current version of the Terms of Use at any time at this page.

We reserve the right, at our sole discretion, to update, change or replace any part of these Terms of Use by posting updates and changes to our website. It is your responsibility to check our website periodically for changes. Your continued use of or access to our website or the Service following the posting of any changes to these Terms of Use constitutes acceptance of those changes.

 

SECTION 17 – CONTACT INFORMATION

Questions about the Terms of Use should be sent to us at staff@drfarrahcancercenter.com

Upon agreeing to these terms and conditions, you gain access to the drfarrahcancercenter.com website and assume total responsibility for any and all actions undertaken by you as a result of your access to the drfarrahcancercenter.com website. You agree and understand that the terms of this agreement shall be binding upon you, your respective heirs, successors, assigns and legal representatives. You understand and agree that all provisions of this Terms of Use agreement that by their nature should survive termination shall survive termination, including, without limitation, ownership provisions, warranty disclaimers, indemnity, licensing in perpetuity and limitations of liability.